Application 077742
- Type
- ANDA
- Sponsor
- PAR PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | EQ 25MG BASE;EQ 3MG BASE | No | No |
| 002 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | EQ 25MG BASE;EQ 6MG BASE | No | No |
| 003 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | EQ 25MG BASE;EQ 12MG BASE | No | No |
| 004 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | EQ 50MG BASE;EQ 6MG BASE | No | No |
| 005 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | CAPSULE;ORAL | EQ 50MG BASE;EQ 12MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077742-001 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | EQ 25MG BASE;EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | |
| A077742-002 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | EQ 25MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | |
| A077742-003 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | EQ 25MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | |
| A077742-004 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | EQ 50MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | |
| A077742-005 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | FLUOXETINE HYDROCHLORIDE; OLANZAPINE | EQ 50MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077742-001 | AB |
| A077742-002 | AB |
| A077742-003 | AB |
| A077742-004 | AB |
| A077742-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077742-001 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A077742-002 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A077742-003 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A077742-004 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A077742-005 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A077742-001 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A077742-002 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A077742-003 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A077742-004 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A077742-005 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077742-001 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077742-002 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077742-003 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077742-004 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077742-005 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077742-001 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077742-002 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077742-003 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077742-004 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077742-005 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077742-001 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077742-002 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077742-003 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077742-004 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077742-005 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077742-001 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077742-002 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077742-003 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077742-004 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077742-005 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077742-001 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077742-002 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077742-003 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077742-004 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077742-005 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077742-001 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 3MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077742-002 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077742-003 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 25MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077742-004 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 6MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077742-005 | OLANZAPINE AND FLUOXETINE HYDROCHLORIDE | EQ 50MG BASE;EQ 12MG BASE | CAPSULE / ORAL | AB | 2012-11-02 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2020-12-22 03:56 UTC | 2020-12 | A077742-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A077742-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A077742-003 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A077742-004 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A077742-005 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A077742-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A077742-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A077742-003 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A077742-004 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A077742-005 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A077742-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A077742-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A077742-003 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A077742-004 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A077742-005 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A077742-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A077742-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A077742-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A077742-004 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A077742-005 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A077742-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A077742-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A077742-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A077742-004 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A077742-005 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077742-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077742-002 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077742-003 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077742-004 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A077742-005 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A077742-001 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A077742-002 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A077742-003 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A077742-004 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A077742-005 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A077742-001 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A077742-002 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A077742-003 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A077742-004 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A077742-005 | AB | 1 | ea1830bbd6c7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine and Fluoxetine | OLANZAPINE AND FUOXETINE | Par Health USA, LLC | 2f6ceda3-3edc-4427-98a6-23e3c930c44d | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 077742 ANDA077742 49884-277 49884-250 49884-251 49884-253 49884-252 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 49884-250 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-250 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-250 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-250 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-250 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-251 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-251 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-251 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-251 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-251 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-252 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-252 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-252 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-252 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-252 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-253 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-253 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-253 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-253 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-253 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-277 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-277 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-277 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-277 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-277 | Olanzapine and Fluoxetine | olanzapine and fuoxetine | Par Pharmaceutical, Inc. | ANDA | Current |